2024 |
10x Genomics Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2024 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
- |
- |
2023 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
466.9 K |
0.1 % |
2023 |
10x Genomics Inc - Ordinary Shares - Class A
|
Independent Director |
336.4 K |
25.4 % |
2022 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
466.4 K |
-0.2 % |
2022 |
10x Genomics Inc - Ordinary Shares - Class A
|
Independent Director |
268.3 K |
-24.7 % |
2021 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
467.1 K |
8.5 % |
2021 |
10x Genomics Inc - Ordinary Shares - Class A
|
Independent Director |
356.1 K |
42.4 % |
2020 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
430.6 K |
-54.4 % |
2020 |
10x Genomics Inc - Ordinary Shares - Class A
|
Independent Director |
250.0 K |
-83.8 % |
2019 |
10x Genomics Inc - Ordinary Shares - Class A
|
Independent Director |
1.5 M |
- |
2019 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
944.1 K |
- |
2018 |
Ultragenyx Pharmaceutical Inc.
|
Independent Director |
- |
- |
2018 |
10x Genomics Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |